Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis
Condition: Relapsing Polychondritis Intervention: Drug: Interleukin-2 Sponsor: Peking University People's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 4, 2019 Category: Research Source Type: clinical trials